Purpose: One manifestation of systemic inequities in communication sciences and disorders (CSD) is the chronic underreporting and underrepresentation of sex, gender, race, and ethnicity in research. The present study characterized recent demographic reporting practices and representation of participants across CSD research. Method: We systematically reviewed and extracted key reporting and participant data from empirical studies conducted in the United States with human participants published in the year 2020 in journals by the American Speech-Language-Hearing Association (ASHA; 407 articles comprising a total of 80,058 research participants, search completed in November 2021). Sex, gender, race, and ethnicity were operationalized per National Institutes of Health guidelines. Results: Sex or gender was reported in 85.5% of included studies; race in 33.7%; and ethnicity in 13.8%. Sex and gender were clearly differentiated in 3.4% of relevant studies. Where reported, median proportions for race and ethnicity were significantly different from the U.S. population, with underrepresentation noted for all non-White racial groups and Hispanic participants. Moreover, 64.7% of studies that reported sex or gender and 67.2% of studies that reported race or ethnicity did not consider these respective variables in analyses or discussions. Conclusions: At present, research published in ASHA journals frequently fails to report key demographic data summarizing the characteristics of participants. Moreover, apparent gaps in the representation of minoritized racial and ethnic groups threaten the external validity of CSD research and broader health care equity endeavors in the United States. Although our study is limited to a single year and publisher, our results point to several steps for readers that may bring greater accountability, consistency, and diversity to the discipline. Supplemental Material: https://doi.org/10.23641/asha.25718412
13 January 2026 in American Journal of Speech-Language Pathology
Purpose: Although discourse analysis has been receiving growing interest among aphasia researchers and speech-language pathologists (SLPs), several key challenges, such as limited time, insufficient training, and a lack of accessible tools, preclude its practical application in clinical settings. To address these barriers, we developed and evaluated a clinical training program for Auditory-Perceptual Rating of Connected Speech in Aphasia (APROCSA; Casilio et al., 2019), a time-efficient and psychometrically robust transcriptionless system for quantifying a range of speech-language impairment features. Method: A collaborative working group was established, comprising five researchers with expertise in discourse analysis in aphasia and eight SLPs who actively worked with individuals with aphasia in clinical or research roles. Through this partnership, SLP members provided feedback regarding their training needs, which informed the creation of a comprehensive training program that included a manual, webinar, and hybrid training sessions. Program effectiveness was measured by comparing SLPs' interrater agreement on six discourse samples before and after the training relative to expert consensus ratings, as well as posttraining perceptions on the program. Adoption of APROCSA into SLPs' work settings at approximately 1 year posttraining was also quantified. Results: Interrater agreement improved as a function of training and newer clinicians appeared to benefit the most from the training. Posttraining perceptions were complementary to the interrater agreement findings, with nearly all SLPs indicating that the training was very helpful. At 1 year posttraining, most SLPs reported using APROCSA, primarily for assessment purposes, highlighting its effectiveness in helping them characterize spoken discourse in clinical contexts. Conclusions: The APROCSA training program addresses key barriers to implementation, with preliminary evidence supporting its effectiveness and adoption into clinical work settings. Results overall support APROCSA's feasibility in clinical use and emphasize the benefits of targeted training for clinical discourse assessment.
10 July 2025 in Journal of Critical Study of Communication and Disability
This editorial introduction celebrates the release of volume three, issue one of the Journal of Critical Study of Communication and Disability (JCSCD), which marks a two-year milestone since the inaugural publication of the journal. We express gratitude for the contributions of the first cohort of editorial board members, authors, reviewers, interns, digital publishing librarian, and interns who made this accomplishment possible. We extend a special thank you to Dr. Yvette Hyter as she ends her service as a co-managing editor. We discuss the evolution and future directions of JCSCD as a dynamic meeting ground for scholars from a wide-ranging and intersectional array of fields with a shared commitment to justice, access, and dignity for all bodyminds and languaging practices.
25 June 2024 in Journal of Critical Study of Communication and Disability
Primary progressive aphasia (PPA) is a neurodegenerative disease involving insidious onset language loss in the context of relatively spared cognitive function, where language is the initial and dominant factor impacting activities of daily living (Mesulam, 2001). Detection and identification of PPA requires a level of interdisciplinary expertise and resources that are not uniformly available across healthcare settings at the local and global levels (Bahia, 2007; Duran-Aniotz et al., 2021; Guimarães et al., 2013; Hogan et al., 2016; Knopman & Roberts, 2011; Onyike et al., 2020; Pijnenburg et al., 2004). This potential inequity raises concerns for increased risk of underdiagnosis, misdiagnosis, and/or delayed diagnosis of PPA, in turn impacting access to the required specialty care. The current study sought to characterize the PPA population at a Southeastern United States academic medical center, and to examine potential delays in PPA diagnosis and access to speech-language pathology services related to social determinants of health. We hypothesized that individuals from minoritized and otherwise disenfranchised groups would have longer duration of time between first reported symptom, and PPA diagnosis. Further, we hypothesized that these groups would be less likely to be referred to speech-language pathology services. Our results revealed a significant lack of sample diversity in terms of race, ethnicity, language practices, and queer identity. Within our overwhelmingly White, non-queer-identifying sample, factors related to rurality and economic status did not predict time to diagnosis or referral to speech pathology. A discussion of PPA and related disorders as they relate to social determinants of health follows.
8 September 2026 in International Journal of Language & Communication Disorders
Introduction: Globally, there is a lack of awareness of rare dementias such as those led by language decline (the primary progressive aphasias, PPA). The main treatment for PPA is speech and language therapy, yet many people are unaware of the benefits and are often not referred on by other health care professionals. Delays in diagnosis can exacerbate a delay in accessing resources such as speech and language therapy which can assist in maintenance of communication and independence. Some people affected by PPA are able to seek out information independently and navigate their own way to these services, but others experience substantial challenges in accessing support. This study was born out of discussions with people affected by PPA who identified an urgent need to raise awareness of PPA and the benefits of speech and language therapy. The aim of the project was to co‐develop a PPA awareness campaign and, through feedback, understand the impact of a co‐produced and delivered awareness campaign on awareness and knowledge of PPA and the role of the speech and language therapy. Methods: This study was informed by the People with Aphasia and Other Layperson Involvement (PAOLI) framework for guiding patient and public involvement (PPI) in aphasia research. Key components of the PPA awareness campaign were co‐developed at a World Café event with 30 people affected by PPA. Consequently, engagement data were collected from social media posts during the 10‐week campaign, and registration and attendance at the co‐planned webinars. A feedback survey was collected from attendees after the event, and a micro‐costing analysis conducted to understand the costs. Results: The 10‐week PPA awareness campaign focused on raising awareness of the role of speech and language therapy for PPA and a bespoke logo was developed that was shared across seven participating countries internationally. Attendees reported increased knowledge of the role of speech and language therapists and valued hearing the voices of people affected by PPA throughout the campaign. Webinar events were well attended across the participating countries with an average of 300 attendees, ranging from 233 in Greece to 369 in the UK. The cost of developing the awareness campaign was calculated at £26.20 per webinar attendee in the UK. Discussion: The PPA awareness campaign was conceived by people affected by PPA and aimed to increase awareness that speech and language therapy can support people affected by the condition. The awareness campaign developed iteratively and concluded with an awareness day event spanning seven‐countries internationally which are all now permanently accessible as resources on the International Speech and Language Therapist / Pathologist PPA network (International SLT/P PPA network) website. Future campaigns will take a more focused approach by targeting more specific audiences such as trainee doctors. The co‐development blueprint for the PPA awareness campaigns provides actionable, field‐tested recommendations for planning future health awareness initiatives. WHAT THIS PAPER ADDS: What is already known on the subject Primary Progressive Aphasia (PPA) is a rare language led dementia for which speech and language therapy is the main treatment. At present, people affected by PPA report a lack of information available about speech and language therapy. This can perpetuate feelings of loneliness and social isolation. What this paper adds to the existing knowledge This paper provides the key components of a co‐developed PPA awareness campaign and describes a collaboration across organisations and countries to deliver the first year of the PPA awareness campaign. Future PPA awareness campaigns will build on this, by targeting specific audiences and aiming to increase knowledge and awareness of the role of the speech and language therapist. What are the clinical implications of this study? Increasing awareness of PPA and the role of the speech and language therapist has been identified by people with lived experience in the UK, as the core care pathway for people with PPA and their families. The PPA awareness campaign has made this information available to people affected by PPA and health care professionals. This includes a set of recommendations for the development of future similar awareness campaigns beyond PPA.